ISCT Open Access Webinars

20 Entries
 
 
24 days ago
Be the first person to recommend this.

You can also read a slide summary of this Town Hall below.

Attachments
4 months ago
Be the first person to recommend this.

Unproven Stem Cell Treatments: Law & Ethics

Presented by the ANZ Legal & Regulatory Affairs (ANZ LRA) Committee  & The Committee on the Ethics of Cell and Gene Therapy (ECGT)  

 
Although ...

Attachments
4 months ago
1 person recommends this.

Particulates in Cell & Gene Therapy Products: A Survey and a Solution

Presented by the ISCT Process Development and Manufacturing Committee

 
Particulates are everywhere ...

Attachments
8 months ago
Be the first person to recommend this.

Challenges and Solutions in CGT Manufacturing Processes - Integration Between Manufacturing Data and Clinical Data Based Upon Automated Cell Culturing Systems

Presented by the ISCT ...

Attachments
10 months ago
Be the first person to recommend this.

#2023
#SCA

Attachments
11 months ago
Be the first person to recommend this.

Commercial Development of CGTs in Korea: Bringing Novel Technologies to Therapeutic Reality

Presented by the ISCT Asia Regional Executive Committees
Part 1 of the ISCT Asia Webinar ...

Attachments
one year ago
Be the first person to recommend this.

Webinar Description:
The cancer vaccine webinar by ISCT is devoted to individuals associated with cancer vaccines, immune effective therapy programs, GMP cell processing laboratories, ...

Attachments
one year ago
Be the first person to recommend this.

Webinar Description:
In the second half of 6-part Cold Chain Webinar Series, we will cover common solutions to issues encountered in logistics and supply of getting ATMPs to intended ...

Attachments
one year ago
Be the first person to recommend this.

Webinar Description:

Investors have access to large amounts of clinical and market data, however they don’t always have visibility to the details of developing, manufacturing, and ...

Attachments
one year ago
Be the first person to recommend this.

Webinar Description:
Hundreds of institutions now have access to commercial CAR T cells, but in parallel many institutions globally are looking to implement a more decentralized approach ...

Attachments